Canadian Urological Association guideline on androgen deprivation therapy: Adverse events and management strategies

  • Andrea Kokorovic
  • Alan I. So
  • Hosam Serag
  • Christopher French
  • Robert J. Hamilton
  • Jason P. Izard
  • Jasmir G. Nayak
  • Fréderic Pouliot
  • Fred Saad
  • Bobby Shayegan
  • Armen Aprikian
  • Ricardo A. Rendon
Keywords: ADT, prostate cancer, CV risk, bone health

Abstract

NA

Published
2021-04-21
How to Cite
Kokorovic, A., So, A. I., Serag, H., French, C., Hamilton, R. J., Izard, J. P., Nayak, J. G., Pouliot, F., Saad, F., Shayegan, B., Aprikian, A., & Rendon, R. A. (2021). Canadian Urological Association guideline on androgen deprivation therapy: Adverse events and management strategies . Canadian Urological Association Journal, 15(6), E307-22. https://doi.org/10.5489/cuaj.7355
Section
CUA Guideline